annual report 2011 - duopharma biotechannual report 2011 building trust life ccm duopharma biotech...

Download Annual Report 2011 - Duopharma BiotechAnnual Report 2011 Building Trust Life CCM DUOPHARMA BIOTECH BERHAD (524271-W) Annual Report 2011 Lot 2599, Jalan Seruling 59, Kawasan 3, Taman

If you can't read please download the document

Upload: others

Post on 18-Feb-2021

0 views

Category:

Documents

0 download

Report

Download

Embed Size (px):

Impress State of the Union - The Document Foundation · 2012-10-08 · 2011-03-04 2011-03-25 2011-04-15 2011-05-06 2011-05-27 2011-06-17 2011-07-08 2011-07-29 2011-08-19 2011-09-09

Cattle Housing Integrated Research Project: Current ... 2014 Monoslo… · 6/23/2011 6/24/2011 6/25/2011 6/26/2011 6/27/2011 6/28/2011 6/29/2011 6/30/2011 7/1/2011 7/2/2011 Concentration

SENIOR MANAGEMENT - Duopharma BiotechWAN AMIR-JEFFERY BIN WAN ABDUL MAJID Age 45 years Gender Male Nationality Malaysian POSITION Chief Strategy Officer DATE OF APPOINTMENT TO KEY

2011 • JULY • 2011 THE CORNERSTONE CONNECTIONstorage.cloversites.com/cornerstonechristianchurch/documents/2011... · 2011 • JULY • 2011 THE CORNERSTONE CONNECTION ... C ongratulations

Grassland Bypass Project Data Collection and Review Team · Oct 2010 Nov 2010 Dec 2010 Jan 2011 Feb 2011 Mar 2011 Apr 2011 May 2011 Jun 2011 Jul 2011 Aug 2011 Sep 2011 Mean Daily

SECTION 03 - Duopharma Biotech

PRESIDENCY OF IMMOVABLE PROPERTY COMMISSION · 99 1219/2011 12 October 2011 143 1263/2011 17 October 2011 100 1220/2011 12 October 2011 144 1264/2011 17 October 2011 101 1221/2011

Fourth Quarter 2012 In thisrepoht:FeuhutQapu2€¦ · Jan-2011 Feb-2011 Mar-2011 Apr-2011 May-2011 Jun-2011 Jul-2011 Aug-2011 Sept-2011 Oct-2011 Nov-2011 Dec-2011 Jan-2012 Feb-2012

[XLS] Object Summary.xlsx · Web view5/26/2010 5/26/2010. 5/2/2011 5/2/2011. 9/30/2011 9/30/2011. 7/6/2011 7/6/2011. 11/28/2011 11/28/2011. 12/6/2011 12/6/2011. 11/28/2011 11/28/2011

UTEQ · 2016. 1. 7. · feb _ 2011 mar _ 2011 abr_ 2011 may. 2011 jun- 2011 jul- 2011 ago- 2011 sep- 2011 oct- 2011 nov- 2011 asr; 2010 dic- 2011 ene - 2012 feb - 2012 imar - 2012

DUOPHARMA BIOTECH BERHAD · 2020. 1. 31. · Disclaimer This presentation may contain forward-looking statements by Duopharma Biotech Berhad that reflect management [scurrent expectations,

Section 04 FINANCIAL - Duopharma Biotech · 2020. 4. 30. · Wan Amir-Jeffery bin Wan Abdul Majid Duopharma Marketing Sdn. Bhd. Urudra a/l N Sarvanantham Wan Amir-Jeffery bin Wan

POSTERS & PRESENTATION SUMMARIES€¦ · POSTERS & PRESENTATION SUMMARIES APRIL 2011 MAY 2011 . POSTERS & PRESENTATION SUMMARIES JUNE 2011 JUNE 2011 . JUNE 2011 SUMMER 2011 POSTERS

cryptocomb.orgcryptocomb.org/DOEORNLFOIALOGS.xlsx · XLS file · Web view1/4/2011 2/2/2011. 1/4/2011 2/2/2011. 1/4/2011 2/2/2011. 1/5/2011 2/3/2011. 1/5/2011 2/3/2011. 1/5/2011 2/3/2011

Aspek Organologis dan Musikologis Suling Kebyarrepository.isi-ska.ac.id/2427/1/I Ketut Yasa.pdf · Suling atau seruling adalah alat musik tiup yang terbuat dari bambu maupun besi

2012 Consumer Experience Full chart deck Updated...2011 May 2011 Jun 2011 2011 Aug 2011 2011 Oct 2011 Nov 2011 Dec 2011 Jan-2012 Feb-2012 10% use at least... 25% use at least... 50%

NOTES TO THE FINANCIAL STATEMENTS...90 CCM Duopharma Biotech Berhad NOTES TO THE FINANCIAL STATEMENTS CCM Duopharma Biotech Berhad is a public limited liability company, incorporated

Duopharma Biotech Berhad · Duopharma Biotech’s Equity Structure 4 DPHARMA (Stock Code –7148) Market capitalization on 12.03.2020 = RM 1.02 bil Share price = RM 1.49

Section 01 ABOUT US - Duopharma Biotech · Dato’ Dr. Zaki Morad Bin Mohamad Zaher Independent Non-Executive Director COMPANY SECRETARY Ibrahim Hussin Salleh License No.: LS0009121

Duopharma Biotech Berhad...• As Korea recognises biotech technologies, Duopharma Biotech may be able to monetise the technologies. • Regulation on stem cell in Malaysia to start

INNOVATING LIFE SCIENCES - Duopharma Biotech

[XLS] · Web view2011 1/3/2011 1/3/2011 1/5/2011 1/7/2011 1/7/2011 1/7/2011 1/7/2011 1/7/2011 1/7/2011 1/7/2011 1/7/2011 1/7/2011 1/11/2011 1/11/2011 1/11/2011 1/11/2011 1/11/2011

CCM DUOPHARMA BIOTECH BERHAD · Disclaimer This presentation may contain forward-looking statements by CCM Duopharma Biotech Berhad that reflect management’scurrent expectations,

CCM DUOPHARMA BIOTECH BERHAD Nurturing Lives€¦ · market. The global biogenerics market has grown at an annual average rate of 70% between 2007 and 2011, and has the potential

EPT 2011 SEPT 2011 SEPT 2011 SEPT 2011 SEPT …...EPT 2011 SEPT 2011 SEPT 2011 SEPT 2011 SEPT 2011 SEPT 2011 SEPT 2011 SEPT 2011 SEPT 2011 SEPT 2011 SEP 165 WEST CENTRAL STREET . NATICK,

CALENDAR OF MAJOR EVENTS - Duopharma Biotech · 2020. 1. 31. · 22 CCM Duopharma Biotech Berhad │ Annual Report 2016 CALENDAR OF MAJOR EVENTS 22 FEB 2016 CCM Pharmaceuticals Sdn

SET MAINAN 2 MAINAN 2 congklak kelereng kartu papan catur buah catur topeng bunga gitar seruling gendang SET MAINAN 2 congklak kelereng kartu papan catur buah catur topeng bunga gitar

Volume 26, Number 1 January 2011 - Narcotics … 2011 15 January 2011 July 2011 15 April 2011 October 2011 15 July 2011 January 2012 15 October 2011 We recently developed worksheets

CCM DUOPHARMA BIOTECH BERHAD (524271-W) (Incorporated …duopharmabiotech.com/wp-content/uploads/2019/04/NOTES-Q3... · 2020-01-31 · A1 Accounting Policies and Method of Computation

Or. German de Jesús Tenorio Vasconcelos.- Secretario de ... · 01/04/2011 16104/2011 16/03/2011 01/04/2011 01/03/2011 16/04/2011 16/03/2011 16/03/2011 01/04/2011 01/04/2011 alta

2011 2011 8 28. 2 2011 3 4 5 2011 2 6 7 2011 3

2011-2011 Handbook

CREATING OPPORTUNITIES - Duopharma Biotech...Selangor Darul Ehsan, Malaysia Tel : 603 - 3323 2759 Fax: 603 - 3323 3923 Annual Report 2016 CREATING OPPORTUNITIES The expansion of our

Encom Discover 2011 & Discover3D 2011 - Pitney Bowesblogs.pitneybowes.dk/files/dk/Insights DK/2011/dag2/B4_Encom... · Encom Discover 2011 & Discover3D 2011 Insights Danmark 2011

(Formerly known as CCM Duopharma Biotech Berhad) …duopharmabiotech.com/wp-content/uploads/2019/04/...Duopharma Biotech Berhad Annual Report 2018 (Formerly known as CCM Duopharma